Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1097777-12-2

Post Buying Request

1097777-12-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1097777-12-2 Usage

General Description

2-[6-(methyloxy)-2-naphthalenyl]-4-pyridinecarboxylic acid is a chemical compound that consists of a naphthalene ring with a methoxy group attached at the 6 position and a pyridine ring with a carboxylic acid group attached at the 4 position. 2-[6-(methyloxy)-2-naphthalenyl]-4-pyridinecarboxylic acid is derived from both naphthalene and pyridine, and it has potential applications in pharmaceuticals and organic synthesis. Its structure and functional groups make it a promising candidate for further research and development in the fields of medicinal chemistry and chemical synthesis. Its unique properties and potential reactivity make it an interesting target for study in the field of organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 1097777-12-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,7,7,7 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1097777-12:
(9*1)+(8*0)+(7*9)+(6*7)+(5*7)+(4*7)+(3*7)+(2*1)+(1*2)=202
202 % 10 = 2
So 1097777-12-2 is a valid CAS Registry Number.

1097777-12-2Downstream Products

1097777-12-2Relevant articles and documents

FARNESOID X RECEPTOR AGONISTS

-

Page/Page column 147-148, (2009/03/07)

The present invention relates to famesoid X receptors (FXR, NR1H4) FXR is a member of the nuclear receptor class of ligand-activate transcription factors More particularly, the present invention relates to compounds useful as agonists for FXR, pharmaceutical formulations comprising such compounds, and therapeutic use of the same Novel isoxazole compounds are disclosed as part of pharmaceutical compositions for the treatment of a condition mediated by decreased FXR activity, such as obesity, diabetes, cholestatic liver disease, liver fibrosis, and metabolic syndrome

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1097777-12-2